Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
02/2006
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006EP1144348B1 Lta 4 hydrolase inhibitors
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732002A Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
02/08/2006CN1731993A Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
02/08/2006CN1730475A Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses
02/07/2006US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
02/07/2006US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/02/2006WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006WO2005090274A8 Process for regioselective preparation of glycerol, derivative and intermediate therefor
02/02/2006US20060025615 Dehalogenation, carboxylation, decarboxylation, salt formation, desalting, oxidative desulfurization, fluorination, acidification, protonation, deprotonation, bromination
02/02/2006US20060025613 Sugar derivatives comprising oxiranes or alpha, beta-unsaturated gamma-lactones, process for their preparation and their utilisation as pesticides
02/02/2006US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
02/02/2006US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/02/2006US20060022176 Photochromic materials
02/02/2006CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/01/2006EP1621598A1 Divinylfluorenes.
02/01/2006EP1501818B8 Alkylene carbonate purification method
02/01/2006EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
02/01/2006EP0817765B1 Stereoselective ring opening reactions
02/01/2006CN1729182A Process for the preparation of propanediol
02/01/2006CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/01/2006CN1729157A Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
02/01/2006CN1727339A Tricyclic compounds, their production and use
02/01/2006CN1727332A Compound in category of aryl methylamino dithio formic ether, preparation method and application
02/01/2006CN1239472C HIV integrase inhibitors
02/01/2006CN1239451C Process for preparing chiral desubstituted carbinol with high selectivity
01/2006
01/31/2006US6991911 for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens
01/26/2006US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
01/26/2006US20060019960 Antitumoral analogs of ET-743
01/26/2006CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
01/25/2006EP1619199A1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates
01/25/2006EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives
01/25/2006EP1618087A2 Antibacterial agents
01/25/2006EP1212318B1 Substituted indolinones as tyrosine kinase inhibitors
01/25/2006EP1097158B1 Ligands for metals and metal-catalyzed processes
01/25/2006CN1726203A Process for producing alkylene carbonate
01/25/2006CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
01/25/2006CN1238351C Substituted benzo 1,3-dioxygen pentacyclic ring derivative, preparing process and uses thereof
01/25/2006CN1238337C Pesticide
01/19/2006WO2006007436A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
01/19/2006WO2006007435A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
01/19/2006WO2005062811A3 Catalytic sulfoxide-promoted c-h oxidation, and regioselective preparation of allylic carboxylates
01/19/2006US20060014752 Heterocyclic anti-epileptogenic agents and methods of use thereof
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/19/2006CA2570614A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
01/18/2006EP1616867A1 Hydroxycarboxylic acid derivatives
01/18/2006EP1616859A1 Substituted cyclohexyl carboxylic acid compounds
01/18/2006EP1615932A2 Podophhyllotoxin derivatives as igf-1r inhibitors
01/18/2006EP1615866A1 Indene derivatives as pharmaceutical agents
01/17/2006US6987193 Illudin analogs useful as antitumor agents
01/17/2006CA2341865C 6-fluorobicyclo[3.1.0]hexane derivatives
01/12/2006US20060009368 Alkylglycidol carbonates as cosurfactants
01/12/2006CA2572350A1 Tetrahydroquinolines
01/11/2006EP1613303A1 Substituted p-diaminobenzene derivatives
01/11/2006CN1720212A Reaction products of 2-propylheptanol with 1-halogen-2,3-epoxypropanes and 1-hydroxy-2,3-epoxypropane
01/11/2006CN1235901C Compounds of podophyllotoxins, application and preparation method
01/11/2006CN1235897C 4-beta-amino-saccharidoid side chain-4-desoxy-4'-demethylpodoph-yllotoxin derivative with antineoplastic activity and its synthesizing process
01/10/2006US6984661 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR)
01/10/2006US6984647 Antiinflammatory agents; analgesics; antiarthritic agents
01/10/2006US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists
01/05/2006WO2006000294A1 Novel diazeniumdiolate compounds, process for the preparation thereof, and therapeutic use thereof
01/05/2006US20060004213 1-Acetoxy-3-(substituted phenyl)propene compounds
01/05/2006US20060004063 Inhibitors of HCV NS5B polymerase
01/05/2006US20060004062 Compounds for inhibiting insulin secretion and methods related thereto
01/05/2006CA2572135A1 Sulfonamide compound
01/04/2006EP1612201A1 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound
01/04/2006EP1611120A1 Novel methods for the treatment of inflammatory diseases
01/04/2006EP1611091A1 Novel compounds
01/04/2006EP1611088A2 Hydroxamates as therapeutic agents
01/04/2006EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin
01/04/2006EP1610792A1 Calcium channel blockers comprising two benzhydril moieties
01/04/2006EP1363873A4 Peptide deformylase inhibitors
01/03/2006CA2244695C Cyclic amic acid derivatives
12/2005
12/29/2005WO2005123711A1 Bicyclol glycosides and the preparation method and uses thereof
12/29/2005WO2005123710A1 Substituted benzoylcyclohexandiones for use as herbicides
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists
12/29/2005US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
12/29/2005DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds
12/29/2005DE102004029307A1 Substituierte Benzoylcyclohexandione als Herbizide Substituted benzoylcyclohexanediones as herbicides
12/29/2005DE102004027912A1 Substituierte Cyclopenten-Verbindungen Substituted cyclopentene compounds
12/29/2005CA2570394A1 Substituted benzoylcyclohexandiones for use as herbicides
12/29/2005CA2569758A1 Extraction of alkaloids from opium
12/28/2005EP1609776A1 Process for production of carbonyl compounds
12/28/2005EP1609775A2 1-acetoxy-3-(substituted phenyl) propen compounds useful as an intermediate material
12/28/2005EP1608615A1 Process for the preparation of propylene glycol
12/28/2005EP1529040B1 Endiandric acid h derivatives as c-maf inhibitors for using against asthma
12/28/2005CN1714076A Novel aryl ureido benzoic acid derivatives and their use
12/28/2005CN1714075A Improved process for the preparation of 1,3-substituted indenes
12/28/2005CN1233640C Process for preparing N-alkyl-3,4-(methylene dioxy) aniline through reduction-alkylation of 3,4-( methylene dioxy) nitrobenzene
12/27/2005CA2160712C Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
12/22/2005WO2005121118A1 Compound having perfluoro(4-methylene-1,3-dioxolane) structure and novel polymer
12/22/2005WO2005121078A2 Substituted cyclopentene compounds
12/22/2005WO2005120148A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
12/22/2005WO2005061443A3 Benzoyl-substituted phenylalanine amides
12/22/2005WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282887 Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 183